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Summary
Interleukin-10 (IL-10) is a key regulator of mucosal homeostasis. In the cur-
rent study we investigated the early events after monoassociating germ-free
(GF) wild-type (WT) mice with an Escherichia coli strain that we isolated
previously from the caecal contents of a normal mouse housed under speci-
fic pathogen-free conditions. Our results show that interferon-c (IFN-c)
secreted by mesenteric lymph node (MLN) cells from both IL-10 deficient
mice and WT mice, stimulated ex vivo with E. coli lysate, was dramatically
higher at day 4 after monoassociation compared with IFN-c secreted by cells
from GF mice without E. coli colonization. Production of IFN-c rapidly and
progressively declined after colonization of WT but not IL-10-deficient
mice. The E. coli lysate-stimulated WT MLN cells also produced IL-10 that
peaked at day 4 and subsequently declined, but not as precipitously as IFN-
c. WT cells that express CD4, CD8 and NKp46 produced IFN-c; WT CD4-
positive cells and B cells produced IL-10. Recombinant IL-10 added to
E. coli-stimulated MLN cell cultures inhibited IFN-c secretion in a dose-
dependent fashion. MLN cells from WT mice treated in vivo with neutraliz-
ing anti-IL-10 receptor antibody produced more IFN-c compared with
MLN cells from isotype control antibody-treated mice. These findings show
that a resident E. coli that induces chronic colitis in monoassociated IL-10-
deficient mice rapidly but transiently activates the effector immune system
in normal hosts, in parallel with induction of protective IL-10 produced by
B cells and CD4+ cells that subsequently suppresses this response to mediate
mucosal homeostasis.
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Introduction
The gastrointestinal tract harbours a complex set of
microbes, particularly in the large intestine, which is
inhabited by approximately 10–100 trillion bacteria com-
prised of more than 1000 different species.1–5 Bacteria
colonize the intestinal lumen after birth and interact with
the host through antigens and adjuvants that stimulate
either pathogenic or protective immune responses.1,6
Interleukin-10 (IL-10) is a regulatory cytokine that is
produced by a wide variety of cell types including T cells, B
cells, macrophages, dendritic cells and epithelial cells.7–12
This cytokine is a key inhibitor of antigen-presenting cell
function and so suppresses effector T-cell responses and
helps to maintain mucosal homeostasis.12–14 Interleukin-10
is associated with immunological tolerance and regulatory
T-cell responses.15–17 The critical role of IL-10 in maintain-
ing intestinal immune regulation is demonstrated by the
observation that conventionally housed IL-10-deficient and
IL-10-receptor-deficient mice spontaneously develop
chronic intestinal inflammation.18,19 In parallel, IL-10 pro-
duced by T cells is necessary for inhibition of colitis in
various murine colitis models.20 In addition to T cells, IL-
10-secreting B cells activated by resident bacteria induce
Abbreviations: GF, germ-free; IFN, interferon; IL, interleukin; IL-10R, interleukin-10 receptor; MLN, mesenteric lymph node;
SPF, specific pathogen free; WT, wild-type
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regulatory type 1 T cells, suppress effector T cells, and inhi-
bit colitis in several murine model systems.21,22 Soon after
IL-10-deficient mice became available, we re-derived them
into germ-free (GF) conditions and observed that the GF
cohort, unlike the conventional IL-10-deficient mice, did
not develop intestinal inflammation or activation of the
gut-associated immune system.23 These results demonstrate
the importance of resident intestinal microorganisms in the
development of intestinal inflammation in IL-10-deficient
mice.
Numerous publications report IL-10-mediated inhibi-
tion of intestinal inflammation and investigators have iden-
tified pivotal molecules in the IL-10 signalling
pathway;14,24,25 however, most of these studies focus on
chronic inflammation. Few have investigated the immune
response at very early time-points after exposure to resi-
dent intestinal bacteria. In a previous study,13 we examined
the early stages of immune activation in experiments
designed to determine the role of T cell-derived IL-10 com-
pared to antigen-presenting-cell-derived IL-10 in regulating
colitis. Our kinetic analysis of cytokine production after
adoptive transfer of T cells to specific pathogen-free (SPF)
immunodeficient hosts demonstrated the rapid induction
of interferon-c (IFN-c) in response to components of resi-
dent intestinal microorganisms. This response was subse-
quently down-regulated in the presence but not in
the absence of IL-10-producing antigen-presenting cells.
These results are particularly interesting because the adop-
tive transfer model permits evaluation of the parameters of
T-cell responses as they develop during homeostatic prolif-
eration. El Aidy et al.26,27 observed similarly rapid induc-
tion of cytokine gene expression after GF wild-type (WT)
mice were colonized with complex murine resident intesti-
nal microbiota. We now report results that confirm and
extend the previous studies, showing that IFN-c and IL-10
were both produced rapidly after GF WT mice were
monoassociated with a single intestinal resident bacteria
designated Escherichia coli NC101 that we isolated from the
caecum of an SPF WT mouse. Interferon-c subsequently
declined; IL-10 also declined, but not as precipitously as
IFN-c. The IFN-c is produced by CD4-positive, CD8-posi-
tive and NKp46-positive cells while CD4-positive cells and
B cells produce IL-10. In vitro addition of recombinant
murine IL-10 suppressed E. coli -induced IFN-c produc-
tion, while blocking the IL-10 receptor (IL-10R) in vivo
enhanced IFN-c production, confirming that IL-10 is
involved in down-regulating the early immune response to
a resident E. coli in normal hosts.
Materials and methods
Mice
Interleukin-10-deficient mice on a 129S6/SvEv back-
ground, and WT 129S6/SvEv mice were maintained in
GF conditions in flexible film isolators at the National
Gnotobiotic Rodent Resource Center at the University of
North Carolina, Chapel Hill and the Gnotobiotic Core of
the Center for Gastrointestinal Biology and Disease
(CGIBD) at North Carolina State University. We confirm
GF status each time we remove mice from isolators for
an experiment. All mice used were older than 8 weeks of
age. Mice were monoassociated with E. coli NC101 by
swabbing the mouth and anus with an overnight bacterial
culture and were subsequently euthanized at different
time-points after initial bacterial colonization. Animal use
protocols were approved by the University of North Car-
olina at Chapel Hill and the North Carolina State Univer-
sity Institutional Animal Care and Use Committees.
Bacterial strain and lysates
The murine E. coli strain designated E. coli NC101 was
originally isolated from WT mice housed in SPF condi-
tions. Lysates were prepared from E. coli cultures grown
in brain–heart infusion broth as described previously.28
Protein concentrations were determined using a standard
assay (Bio-Rad Laboratories, Hercules, CA) and sterility
of the lysates was confirmed by culturing on brain–heart
infusion agar plates. Lysates were divided into aliquots
and stored at 80°.
Mesenteric lymph node cell cultures
Mesenteric lymph nodes (MLN) were collected from
individual mice, teased gently and the cell suspension
was passed through a 40-lm filter (BD Falcon, Franklin
Lakes, NJ). Unseparated MLN cells (4 9 105 cells per
well) were stimulated with 1 or 10 lg/ml E. coli NC101
lysate or cultured in medium alone in 96-well flat-bot-
tom plates (Costar, Corning, NY) for 72 hr at 37° in a
humidified incubator with 5% CO2. Culture medium
was RPMI-1640 (Cellgro, Manassas, VA) supplemented
with 5% heat inactivated fetal calf serum, 2 mM L-gluta-
mine, 1 mM sodium pyruvate, 005 mM 2-mercaptoetha-
nol and 50 lg/ml gentamicin. Culture supernatants were
collected for cytokine analysis and frozen in aliquots at
20°.
For evaluation of cytokine-producing cells, MLN cells
were stimulated overnight with 10 lg/ml E. coli NC101
lysate. Cells were then re-stimulated with 100 ng/ml PMA
(Sigma-Aldrich, St Louis, MO) plus 1 lg/ml ionomycin
(Tocris Bioscience, Minneapolis, MN) for 5 hr. Golgi
stop (BD Biosciences, San Diego, CA) was added during
the last 4 hr.
Recombinant IL-10 treatment and IL-10R blockade
To evaluate the effects of exogenous IL-10, recombinant
murine IL-10 (PeproTech, Rocky Hill, NJ) was added to
ª 2016 John Wiley & Sons Ltd, Immunology, 148, 304–314 305
IL-10 regulation in ex-germ-free mice
MLN cultures at 0, 250 pg/ml, 500 pg/ml, 1000 pg/ml, or
2000 pg/ml.
To block IL-10 signalling in vivo, 05 mg per mouse of
anti-IL-10R-specific antibody (clone 1B1.3A; BioXCell,
West Lebanon, NH) or purified rat IgG1 isotype control
antibody (clone HRPH; BioXCell) was injected intraperi-
toneally 1 day before, 2 days after and 5 days after
monoassociation with E. coli NC101. Mice were eutha-
nized on day 7 after E. coli monoassociation. The MLN
cells were prepared and stimulated with E. coli NC101
lysate as described above.
Cytokine measurements
To measure the amount of IFN-c or IL-10 secreted by
stimulated MLN cells, ELISAs were performed by staff of
the Advanced Analytics Core of the CGIBD at the
University of North Carolina at Chapel Hill. The ELISA
sets for murine IFN-c (catalogue no. 551866) and murine
IL-10 (catalogue no. 555252) were from BD Biosciences.
Assays were performed according to the manufacturer’s
protocols. Cytokine levels were measured in triplicate
culture supernatants and amounts were determined by
comparison with standard curves generated by using the
appropriate recombinant cytokine.
Real-time polymerase chain reaction
Total RNA from transverse colon was extracted using an
RNeasy Mini Kit (Qiagen Sciences, Valencia, CA) follow-
ing the manufacturer’s instructions and treated with
amplification-grade DNase Ι (Qiagen Sciences). First-
strand complementary DNA was synthesized using a
Tetro cDNA Synthesis Kit (Bioline, Taunton, MA) and
treated with Ribonuclease H (Invitrogen, Carlsbad, CA).
Quantitative RT-PCR was performed on a QuantStudio 6
Flex Real-Time PCR System (Life Technologies, Carlsbad,
CA) using SYBR green (Bio-Rad) to quantify the gene
expression of IFN-c, IL-10, IL-1b and IL-6. Each sample
was analysed in triplicate and the results were normalized
to the housekeeping gene GAPDH.
Flow cytometry
Antibodies used to enumerate cell subsets directly after
MLN harvest were peridinin chlorophyll protein-labelled
anti-mouse CD4, phycoerythrin-labelled anti-mouse CD8,
or FITC-labelled anti-mouse CD45R/B220 (BD Bio-
sciences). Antibodies used to detect cell surface molecules
in intracellular cytokine detection experiments were phy-
coerythrin-labelled anti-mouse CD4, CD8, CD19, CD11b
and CD335 (NKp46). Alexa Fluor 488 labelled anti-IFN-c
or anti-IL-10 were used to enumerate cytokine-producing
cells (eBioscience, San Diego, CA). MLN cells were stimu-
lated for intracellular cytokine detection as described
above, collected and incubated with anti-CD antibodies
for 30 min at 4°. Cells were washed, then fixed and per-
meabilized using the BD Cytofix/Cytoperm Fixation/
Permeabilization Kit (BD Biosciences) according to the
manufacturer’s instructions before incubating with anti-
IFN-c, anti-IL-10, or isotype control antibody for 1 hr at
4°. Cells were washed and analysed on an LSRII flow
cytometer (BD Biosciences). We gated on the events for
analysis based on forward and side scatter characteristics
of viable cells. To determine the proportions of cytokine-
positive cells among cell subsets, we gated on the cell-
surface-marker-positive populations.
Data analysis
All statistics were performed using GRAPHPAD PRISM 5.0
software (GraphPad, San Diego, CA). We used two-tailed
Student’s t-tests for comparisons between two groups.
Comparisons between three or more experimental groups
were analysed using one-way analysis of varaince with
Tukey’s multiple-comparison post-test. P-values < 005
were considered significant.
Results
Kinetics of IFN-c production in E. coli NC101
monoassociated mice
To evaluate intestinal bacteria-induced immune responses
in the intestinal tract upon bacterial colonization, we used
129SvEv WT and IL-10-deficient mice that were born in
GF conditions and monoassociated with a non-patho-
genic murine strain of Escherichia coli, designated E. coli
NC101.28 Escherichia coli NC101 shares phylogenetic and
genomic characteristics with several human and canine
strains of adherent/invasive E. coli.29 However, our previ-
ous results show that this organism is not pathogenic
because inflammation does not develop in WT mice.28
At different time-points after monoassociation, we har-
vested MLN and stimulated the cells in vitro with bacterial
lysates containing components of E. coli NC101. We then
measured IFN-c and IL-10 secretion in culture super-
natants. As shown in Fig. 1, we found that IFN-c produced
by unfractionated MLN cells from both IL-10-deficient and
WT mice was dramatically higher at day 4 after coloniza-
tion compared with GF mice. The IFN-c remained consis-
tently high in supernatants of E. coli lysate-stimulated IL-
10-deficient MLN cells obtained at day 7 and 30 after
monoassociation, corroborating our previously published
results,28,30 whereas amounts of IFN-c rapidly declined
with time after colonization of WT mice (Fig. 1a,b). We
tested two different concentrations of E. coli NC101 lysate,
10 and 1 lg/ml, for in vitro re-stimulation. Results were
consistent for both doses (data for cells stimulated with
1 lg/ml not shown). We also evaluated IL-17 production
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in the supernatants of stimulated MLN cells and IL-12p40
production in colon explant cultures. Interleukin-17 secre-
tion by MLN cells from IL-10-deficient mice followed the
same kinetics after E. coli monoassociation as IFN-c; how-
ever, MLN cells from WT mice did not produce detectable
IL-17 (data not shown). Likewise, IL-12p40 in colonic cul-
ture supernatants from IL-10-deficient mice increased with
time after monoassociation but was undetectable in the
supernatants of colon tissue from WT mice (data not
shown).
We next investigated IFN-c mRNA expression in the
transverse colon of GF and E. coli monoassociated WT
mice. The IFN-c mRNA expressed in the transverse colon
showed the same pattern as IFN-c production in the super-
natants of bacterial lysate-stimulated WT MLN cells, with
significantly higher IFN-c mRNA levels 4 days after
monoassociation with E. coli compared with GF and lower
amounts at later time-points (Fig. 1c). Together, these data
show that IFN-c is produced in normal, WT mice at early
time-points in response to resident intestinal bacteria.
Kinetics of IL-10, IL-1b and IL-6 production in E. coli
NC101 monoassociated mice
Interleukin-10-mediated inhibition of IFN-c production
has been established in numerous model systems.12,31,32
Therefore, we explored IL-10 production in the same
kinetic study. We measured IL-10 secretion in supernatants
of E. coli lysate-stimulated unseparated MLN cells and IL-
10 mRNA expression in transverse colon from the same
monoassociated WT mice. We found that IL-10 secretion
in the supernatants was higher at day 4 after colonization
compared with GF levels and decreased thereafter (Fig. 2a).
Interleukin-10 mRNA expression in transverse colon from
WT mice showed the same patterns with higher levels of
IL-10 mRNA at day 4 after monoassociation compared
with GF mice, progressively decreasing at later time-points
(Fig. 2b). Together, these results show that IFN-c and IL-
10 are produced rapidly and concomitantly in normal hosts
upon bacterial monoassociation.
We also quantified IL-1b and IL-6 mRNA expression
in the transverse colon from monoassociated WT mice
(Fig. 3). The IL-1b mRNA expression was approximately
fourfold higher 4 days after colonization compared with
GF, then decreased at later time-points (Fig. 3a). Inter-
leukin-6 mRNA expression (Fig. 3b) was similar to IL-1b,
with fivefold higher levels at day 4 compared with GF fol-
lowed by a subsequent decline. These data show that like
IFN-c and IL-10, both IL-1b and IL-6 are activated
rapidly after monoassociation of normal mice with a sin-
gle non-pathogenic bacterial species, then are subse-
quently down-regulated.
Cell number and phenotype
While the total number of cells obtained from MLN of
E. coli monoassociated mice was significantly higher than
the number harvested from MLN of GF mice (Fig. 4c), the
proportions of CD4-positive cells, CD8-positive cells and B
cells in MLN of GF and E. coli monoassociated mice were
essentially the same (Fig. 4a), with the exception of a
slightly higher percentage of CD4-positive cells at 14 days
after colonization with E. coli. Therefore, the increased
amounts of IFN-c (Fig. 1b) and of IL-10 (Fig. 2a) secreted
by E. coli lysate-stimulated MLN cells obtained at day 4
after E. coli monoassociation is not the result of changes in
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Figure 1. Kinetics of interferon-c (IFN-c) production in 129SvEv wild-type (WT) and interleukin-10 (IL-10) -deficient mice monoassociated with
Escherichia coli NC101. (a) IFN-c production by unseparated mesenteric lymph node (MLN) cells from germ-free (GF) or E. coli NC101 monoas-
sociated IL-10-deficient mice, 129SvEv background. (b) IFN-c production by unseparated MLN cells from GF or E. coli NC101 monoassociated
129SvEv WT mice. MLN cells were stimulated in vitro with 10 lg/ml E. coli NC101 lysate. Supernatants were collected 72 hr later and IFN-c was
quantified by ELISA. (c) IFN-c mRNA expression in transverse colon of GF or E. coli NC101 monoassociated 129SvEv WT mice determined by
quantitative PCR. Copy number is normalized to GAPDH and expressed as fold change relative to GF mice. Each dot represents an individual
mouse analysed in either two independent experiments (GF or day 4, 7, 14, 30 WT mice or GF IL-10-deficient mice) or one experiment (IL-10-
deficient mice day 4, 7 and 30). Day after monoassociation is indicated on the x-axis. Data were analysed using one-way analysis of variance with
Tukey’s multiple-comparison post-test. P-values indicate statistically significant differences between IFN-c produced by E. coli NC 101 lysate-sti-
mulated MLN cells in (a) and (b) or IFN-c mRNA expressed in transverse colon in (b) from GF mice compared with mice at 4, 7, 14 or 30 days
after monoassociation with E. coli NC101. In addition, statistically significant differences in (b) 4-day versus 7-day P < 005, 4-day versus 14-day
P < 005, 4-day versus 30-day P < 0001; in (c), 4-day versus 7-day P < 0001, 4-day versus 14-day P < 001, 4-day versus 30-day P < 0001.
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cell subset proportions among the fixed number of MLN
cells (4 9 105 per well) from GF and E. coli monoassoci-
ated mice that were stimulated in vitro.
Cell types that produce IFN-c and IL-10
Next we designed experiments to determine which types
of cells in MLN produce IFN-c and IL-10 after normal
mice are monoassociated with intestinal bacteria. We har-
vested MLN cells from WT mice monoassociated with
E. coli NC101 for 4 days and re-stimulated them with
E. coli lysate overnight, followed by a 5-hr stimulation
with ionomycin plus PMA. For comparison, we also eval-
uated MLN cells from GF WT mice stimulated according
to the same activation protocol. Representative intracellu-
lar cytokine analysis using MLN cells from E. coli
monoassociated mice (Fig. 5a) shows that a small propor-
tion of CD4+ cells and a higher proportion of CD8+ cells
produce IFN-c. Cells that express the NK cell and innate
lymphoid cell marker NKp4633,34 also produce IFN-c. IL-
10 production can be readily detected in cells that express
CD19; a smaller proportion CD4+ cells produce IL-10.
Interestingly, the potent activation signals provided by
in vitro stimulation with E. coli lysate followed by
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Figure 2. Kinetics of interleukin-10 (IL-10) production in 129SvEv wild-type (WT) mice monoassociated with Escherichia coli NC101. (a) IL-10
production by unseparated mesenteric lymph node (MLN) cells from germ-free (GF) or E. coli NC101 monoassociated 129SvEv WT mice. Day
after monoassociation is indicated on the x-axis. MLN cells were stimulated in vitro with 10 lg/ml E. coli NC 101 lysate. Supernatants were col-
lected 72 hr later and IL-10 was quantified by ELISA. (b) IL-10 mRNA expression in transverse colon of GF or E. coli NC101 monoassociated
129SvEv WT mice determined by quantitative PCR. Copy number is normalized to GAPDH and expressed as fold change relative to GF. Each
dot represents an individual mouse evaluated in experiments described for Figure 1. Data were analysed using one-way analysis of variance with
Tukey’s multiple-comparison post-test. P-values indicate statistically significant differences between IL-10 produced by E. coli NC 101 lysate-sti-
mulated MLN cells in (a) or IL-10 mRNA expressed in transverse colon in (b) from GF mice compared with mice at 4, 7, 14 or 30 days after
E. coli NC101 monoassociation. In addition, statistically significant differences in (a), 4-day versus 7-day not significant, 4-day versus 14-day not
significant, 4-day versus 30-day P < 0001; in (b) 4-day versus 7-day not significant, 4-day versus 14-day P < 001, 4-day versus 30-day P < 005.
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Figure 3. Kinetics of interleukin-1b (IL-1b) and IL-6 expression in transverse colon of 129SvEv wild-type (WT) mice monoassociated with
Escherichia coli NC101. (a) IL-1b mRNA expression in transverse colon of germ-free (GF) or E. coli NC101 monoassociated 129SvEv WT mice
determined by quantitative PCR. Day after monoassociation is indicated on the x-axis. Copy number is normalized to GAPDH and expressed as
fold change relative to GF. Each dot represents an individual mouse. Data were analysed using one-way analysis of variance with Tukey’s multi-
ple-comparison post-test. P-values indicate statistically significant differences between IL-1b expressed in transverse colon from GF mice com-
pared with mice at 4, 7, 14 or 30 days after monoassociation. In addition, statistically significant differences comparing 4-day versus 7-day
P < 001 4-day versus 14-day P < 0001 4-day versus 30-day not significant. (b) IL-6 mRNA expression in transverse colon of GF or E. coli
NC101 monoassociated 129SvEv WT mice determined by quantitative PCR. Copy number is normalized to GAPDH and expressed as fold change
relative to GF. Each dot represents an individual mouse evaluated in experiments described for Fig. 1. Data were analysed using one-way analysis
of variance with Tukey’s multiple-comparison post-test. P-values indicate statistically significant differences between IL-6 expressed in transverse
colon from GF mice compared with mice at 4, 7, 14 or 30 days after monoassociation. In addition, statistically significant differences in compar-
ing 4-day versus 7-day P < 005, 4-day versus 14-day P < 0001, 4-day versus 30-day P < 0001.
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ionomycin plus PMA are sufficient for detection of cyto-
kine-producing cells in MLN of GF mice (Fig. 5b,c).
Although the amounts of IFN-c in supernatants of MLN
cells from GF mice stimulated with E. coli lysate for 72 hr
ranged from undetectable to ~06 ng/ml (Fig. 1b), the
intracellular IFN-c results show that MLN cells from GF
mice have the capacity to produce this cytokine. How-
ever, MLN from GF mice contain fewer IFN-c producing
CD4-positive and NKp46-positive cells compared with
MLN from E. coli monoassociated mice (Fig. 5b).
We have also determined cytokine-producing cells as a
proportion of each MLN cell subset. The results in
Table 1 show that although only 044% of MLN cells
from mice monoassociated with E. coli express NKp46,
an average of 12% of these cells produce IFN-c. A similar
proportion of CD8-positive cells produce this cytokine,
whereas IL-10 is produced by much lower proportions of
CD4-positive (025%) or CD19-positive (14%) cells.
Recombinant IL-10 treatment in vitro
We then evaluated the effects of exogenous IL-10 on
IFN-c production in vitro in our model system. We har-
vested MLN cells from WT mice monoassociated with
E. coli NC101 for 4 days and stimulated the cells with
E. coli NC101 lysate in the presence of 0, 250, 500, 1000
or 2000 pg/ml recombinant IL-10. As shown in Fig. 6,
addition of recombinant IL-10 caused a dose-dependent
decrease in IFN-c production by MLN cells from each
mouse evaluated.
Interleukin-10 receptor blockade in vivo
To determine the role of endogenous IL-10 in the
immune response that develops in vivo, we investigated
whether blockade of IL-10 signalling will regulate IFN-c
secretion. Either anti-IL-10R-specific antibody or isotype
control antibody was given 1 day before, 2 days after and
5 days after colonization of GF mice with E. coli NC101
and the mice were evaluated 7 days after monoassocia-
tion. Interferon-c measured in supernatants of E. coli
NC101 lysate-activated MLN cells from anti-IL-10R-trea-
ted mice was significantly higher than in supernatants of
MLN cells from mice given isotype control antibody
(Fig. 7a). The IFN-c mRNA expression in the transverse
colon from anti-IL-10R antibody-treated mice was also
significantly higher compared with isotype-control-treated
mice (Fig. 7b). In addition, we detected higher expression
of both IL-1b and IL-6 mRNA in intestinal tissue of anti-
IL10R-treated mice compared with isotype-control-treated
mice (Fig. 7c,d). These data show that blockade of IL-10
signalling in vivo by anti-IL-10 receptor antibody
increased IFN-c production and also mRNA expression
of several cytokines, and indicate that endogenous IL-10,
produced at early time-points after exposure to commen-
sal bacteria, plays a role in suppressing these immune
responses.
Discussion
The intestine of normal adult hosts contains a fully com-
petent immune system and the lumen is occupied by
enormous numbers of microorganisms that produce
numerous components with the potential to activate
innate and acquired immune responses. However, the
normal intestinal tract is in a state of “physiologic inflam-
mation” devoid of overt aggressive responses to luminal
microbes and their products. Here we report the results
of our studies that were designed to elucidate the
immune response in the intestinal tract after initial expo-
sure of normal lamina propria host cells and tissues to
resident microorganisms. We demonstrate that a single
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Figure 4. Total cell number and cell subsets in mesenteric lymph nodes (MLN) of 129SvEv wild-type (WT) mice monoassociated with Escheri-
chia coli NC101 or germ-free (GF). Unseparated MLN cells from GF or E. coli NC101 monoassociated 129SvEv WT mice were collected and
analysed by flow cytometry in experiments described for Fig. 1. (a) Percent CD4-positive cells, CD8-positive cells, or B cells in MLN, (b) Total
numbers of CD4-positive cells, CD8-positive cells, or B cells in MLN. In (a) and (b), data are presented as mean  SEM. Asterisks indicate sta-
tistically significant differences compared with GF in each cell type. *P < 005, **P < 001, ***P < 0001. (c) Total MLN cell numbers. Each dot
represents an individual mouse evaluated in experiments described for Fig. 1. P-values indicate statistically significant differences in total numbers
of MLN cells obtained from mice at 4, 7, 14 or 30 days after monoassociation with E. coli NC 101 compared with MLN cells obtained from GF
mice. Data were analysed using one-way analysis of variance with Tukey’s multiple-comparison post-test.
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strain of non-pathogenic E. coli rapidly induces a tran-
sient innate and adaptive effector immune response in
previously GF mice, and that IL-10 produced by B cells
and CD4+ cells is a key mediator of the subsequent sup-
pression of this response.
We initially embarked on the studies described in this
report because we observed an early and then rapidly
down-regulated immune response in the WT mice that
served as controls for our experiments investigating
intestinal inflammation in IL-10-deficient mice colonized
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Figure 5. Cell types that produce interferon-c (IFN-c) and interleukin-10 (IL-10). Unseparated mesenteric lymph node (MLN) cells from 129SvEv
wild-type (WT) mice monoassociated with Escherichia coli NC101 for 4 days or from 129SvEv WT germ-free (GF) mice were stimulated overnight
with 10 lg/ml E. coli NC101 lysate, followed by 5 hr with ionomycin plus PMA. Golgi stop was added during the last 4 hr. (a) Representative flow
cytometry plots showing IFN-c- or IL-10-producing CD4, CD8, CD19, CD11b and NKp46 cells in MLN from E. coli monoassociated mice, (b) mean
percent (minus mean percent isotype control)  SEM of IFN-c-positive MLN cells from GF mice (n = 6) or E. coli monoassociated mice (n = 4),
(c) mean percent (minus mean percent isotype control)  SEM of IL-10-positive MLN cells from GF mice or E. coli monoassociated mice. All four
E. coli monoassociated mice were evaluated in one experiment, representative of three separate experiments. The six GF mice were evaluated in two
separate experiments, three mice in each. Data were analysed by unpaired Student’s t-test. Asterisks indicate statistically significant differences.
**P < 001, ***P < 0001. No significant differences were observed for IL-10 detection in any of the cell types evaluated.
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with normal resident bacteria. Subsequently, in a separate
study, we demonstrated a similar phenomenon at the ear-
liest time-point evaluated (1 week) after adoptive transfer
of IL-10-deficient CD4+ T cells into Rag2/ immunode-
ficient SPF recipients.13 The Rag2/ recipients were
crossed to normal mice or to IL-10-deficient mice provid-
ing either Rag2/ 9 IL-10+/+ or Rag2/ 9 IL-10/
recipients. These mice were born and raised under SPF
conditions and therefore harbour a full complement of
resident microorganisms, but they lack lymphoid cells
before adoptive transfer and so provide an environment
for homeostatic proliferation of donor cells. Relatively
high and also very similar amounts of IFN-c were pro-
duced by MLN cells obtained from both recipient types
1 week after T-cell transfer. By 2 weeks, the MLN cells
obtained from IL-10-replete but not IL-10-deficient recip-
ients no longer produced IFN-c. These results indicate
that the transferred T cells that undergo homeostatic pro-
liferation in SPF Rag2/ recipients are rapidly activated
to produce IFN-c in vivo by components of the intestinal
microbiota, and this early IFN-c response is inhibited by
recipient-derived IL-10 produced by non-lymphoid cells.
In the experiments described in the current report, all
of the components of the immune system are simultane-
ously exposed to luminal bacteria, whereas in the adop-
tive transfer model we were able to observe the adaptive
immune response of the transferred CD4+ T cells upon
their activation in vivo by resident microbiota. The con-
clusion is similar in both model systems, namely that
resident bacteria rapidly activate lymphoid cells (primarily
CD8-positive cells but also cells that express CD4 or
NKp46) to produce IFN-c and that IL-10 plays a key role
in subsequent suppression of this response. In the adop-
tive transfer model, we concluded that non-lymphoid
cells of the Rag2/ recipients produce immunoregulatory
IL-10 because the transferred CD4+ T cells were obtained
from IL-10-deficient donors.13 In the model using E. coli
monoassociated WT mice described in the current report,
we identified MLN CD4+ cells and B cells that produce
IL-10 after in vitro re-stimulation with E. coli lysates. It is
likely that other cell types, including myeloid cells and
possibly also NK cells and innate lymphoid cells are cap-
able of producing IL-10; however, we did not detect IL-
10 production by CD11b-positive MLN cells or NKp46-
positive MLN cells from E. coli monoassociated mice.
Numerous studies have identified a critical role for IL-
10 in maintaining intestinal homeostasis.14,35 Both IL-10-
deficient mice18 and IL-10R-deficient mice19 sponta-
neously develop colitis that can be ameliorated by admin-
istration of exogenous IL-10 immunoglobulin fusion
protein that mimics IL-10 activity.36 Our focus on IL-10
in the present study stems from previous investigations
using SPF and gnotobiotic IL-10-deficient mice as rodent
models of chronic intestinal inflammation.13,23,28 There-
fore, in the current experiments, we either provided
exogenous recombinant IL-10 in vitro or injected anti-IL-
10R-specific antibody in vivo to directly evaluate the role
of IL-10 during the initial period after monoassociation
Table 1. Proportion of interferon-c- or IL-10-positive cells in mesenteric lymph node cell subsets
IFN-c positive cells
Germ-free E. coli monoassociated for 4 days
Percent of subset
in MLN1
Percent IFN-c-positive
of subset2
Percent of subset
in MLN
Percent IFN-c-positive
of subset
CD4 328  16 074  006 315  19 113  006**
CD8 148  07 1068  083 123  07 1146  055
NKp46 039  001 355  083 044  001 1242  123***
IL-10 positive cells
Germ-free E. coli monoassociated for 4 days
Percent of subset
in MLN
Percent IL-10 positive
of subset3
Percent of subset
in MLN
Percent IL-10 positive
of subset
CD4 328  16 017  004 315  19 025  004
CD19 375  20 140  005 435  17 143  007
1Values represent mean  SEM of cells expressing the indicated cell surface marker evaluated after overnight stimulation with E. coli NC101
lysate followed by 5 hr incubation with ionomycin plus PMA, with Golgi stop during the last 4 hr. MLN from E. coli NC101 monoassociated
mice n = 4; MLN from GF mice n = 6.
2Values represent mean  SEM of the proportion of IFN-c positive cells determined after gating on each subset.
3Values represent mean  SEM of the proportion of IL-10 positive cells determined after gating on each subset.
**P < 001 compared to dual CD4 positive – IFN-c positive cells in MLN of GF mice; ***P < 0001 compared to dual NKp46 positive – IFN-c
positive cells in MLN of GF mice. Otherwise differences between percent of cytokine positive cells of each subset from E. coli monoassociated
and GF mice are not statistically significant.
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of GF mice with E. coli NC101. The results of these stud-
ies indicate that IL-10 signalling indeed inhibits IFN-c
production and are therefore consistent with the conclu-
sion that IL-10 plays a key role in maintaining a quies-
cent immune response in the intestinal tract. This
conclusion is supported by the observations of Berg
et al.37 that systemic administration of recombinant IL-10
in vivo can attenuate the onset of colitis in IL-10-deficient
mice and prevent progression of inflammation, but not
reverse established colitis.
Our results confirm and extend the comprehensive
analyses published by El Aidy et al.26,27 showing immune
activation at early time-points after colonizing GF
mice with complex faecal microbiota obtained from con-
ventionally housed normal mice. Both our study and El
Aidy’s results show that (i) the mucosal immune system
recognizes and reacts to the components of bacteria that
normally reside in the intestinal tract, and (ii) that GF
mice have a fully functional immune system, with the
capacity to respond rapidly, demonstrated by activation
of both innate and adaptive immune responses following
bacterial colonization. The maturation from a naive to an
activated state proceeds very rapidly upon microbial
exposure of GF mice, even when the mice are monoasso-
ciated with a single species of non-pathogenic intestinal
bacteria, namely E. coli NC101. Of note, E. coli NC101 is
an example of an adherent/invasive E. coli strain29 that
has the capacity to induce bacterial antigen-specific
chronic T-cell-mediated colitis in IL-10-deficient mice.28
As we show in the current report, the same organism can
also activate regulatory responses, including production
of IL-10 in IL-10 replete WT mice.
Our study expands on that of El Aidy et al. in several
key areas. We investigated the kinetics of immune sys-
tem activation of normal GF mice elicited by exposure
to a single well-studied strain of non-pathogenic E. coli
rather than to the multitude of normal resident
microbes. In addition, our in vitro and in vivo results
identify the key role of IL-10 in suppressing the initial
activation of the immune system of normal germ-free
mice after bacterial colonization, and we identified B
cells and CD4+ cells in MLN as the sources of regulatory
IL-10. It is also important to note that in our study, GF
inbred 129S6/SvEv mice are the hosts. El Aidy et al. used
GF C57BL/6 mice. There are many genetic and func-
tional differences between these two strains. For example,
SPF IL-10-deficient mice backcrossed to C57BL/6 mice
are relatively resistant to the development of intestinal
inflammation compared with SPF IL-10-deficient mice
on the 129S6/SvEv background.37 As another example of
the difference between these two inbred strains, the
ileum of SPF and GF C57BL/6 mice contains a higher
proportion of lysozyme-containing Paneth cells and
higher levels of mRNA expression of several isoforms of
a-defensin compared with the same tissue obtained from
SPF and GF 129SvEv mice.38 Therefore, demonstrating
consistent results using a different inbred mouse strain
strengthens the overall conclusion of our study and that
of El Aidy et al. that non-pathogenic bacteria first acti-
vate and then induce immune regulation in the intestinal
tract of normal hosts.
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Figure 6. Interferon-c (IFN-c) production by mesenteric lymph
nodes (MLN) cells treated with recombinant interleukin-10 (IL-10)
in vitro. IFN-c production by unseparated MLN from 129SvEv wild-
type (WT) mice monoassociated with Escherichia coli NC101 for
4 days. MLN cells were stimulated in vitro with 10 lg/ml E. coli
NC101 lysate. Supernatants were collected 72 hr later and IFN-c was
quantified by ELISA. Cultures contained 0, 250, 500, 1000 or
2000 pg/ml rIL-10 added at the time of in vitro stimulation. (a)
Mean  SEM of IFN-c produced by cells from individual mice. Data
were analysed by unpaired Student’s t-test. Asterisks indicate statisti-
cally significant differences comparing IFN-c in supernatants of cul-
tures without rIL-10 to IFN-c in supernatants of cultures containing
2000 pg/ml rIL-10. **P < 001, ***P < 0001. (b) Fold change in
IFN-c compared with amounts produced by cells cultured without
rIL-10. MLN cultures contain 0, 250, 500 or 2000 pg/ml rIL-10
(n = 6 mice); MLN cultures contain 1000 pg/ml rIL-10 (n = 4
mice). Each dot represents an individual mouse. Data were analysed
by one-way analysis of variance with Tukey’s multiple-comparison
post-test. P-values indicate statistically significant differences com-
pared with cultures without added rIL-10.
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Taken together, our results demonstrate that the gut-
associated immune system of normal GF mice recognizes
and rapidly responds to a non-pathogenic strain of
E. coli, with an initial response that includes production
of pro-inflammatory cytokines. This response rapidly pro-
gresses to a regulated homeostatic immune profile with
low IFN-c, IL-1b and IL-6 levels in the presence of sus-
tained bacterial activation of immunoregulatory IL-10.
Hence intestinal IL-10 signalling is a key factor in sup-
pressing the host’s mucosal effector immune response to
resident bacterial components.
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